Cargando…

Fatty liver disease reverses the obesity paradox in chronic kidney disease stages 3–5: A follow‐up study of NHANES III

High body mass index (BMI) has been associated with better survival in patients with end‐stage kidney disease. Individuals with fatty liver disease (FLD) have a higher risk of chronic kidney disease. It remains unclear whether the survival benefit of high BMI in patients with chronic kidney disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jiaofeng, Zhang, Min, Wu, Yinlian, Wang, Mingfang, Zhu, Yueyong, Lin, Su
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592766/ https://www.ncbi.nlm.nih.gov/pubmed/36125132 http://dx.doi.org/10.1002/hep4.2086

Ejemplares similares

MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease
por: Huang, Jiaofeng, et al.
Publicado: (2021)

Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease
por: Chen, Xiaoning, et al.
Publicado: (2022)

Procalcitonin and Liver Disease: A Literature Review
por: Dong, Ruolin, et al.
Publicado: (2018)

Is Toxoplasma gondii infection correlated with nonalcoholic fatty liver disease?- a population-based study
por: Huang, Jiaofeng, et al.
Publicado: (2018)

The Risk of Acute Kidney Injury in Hepatitis B Virus-Related Acute on Chronic Liver Failure with Tenofovir Treatment
por: Zhang, Kai, et al.
Publicado: (2020)

MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
por: Huang, Jiaofeng, et al.
Publicado: (2021)

The Relationship between Nonalcoholic Fatty Liver Disease and Retinopathy in NHANES III
por: Lin, Tzu-Yu, et al.
Publicado: (2016)

The Association between Meteorological Factors and the Prevalence of Acute-on-chronic Liver Failure: A Population-based Study, 2007–2016
por: Lin, Su, et al.
Publicado: (2019)

Evaluating the global, regional, and national impact of syphilis: results from the global burden of disease study 2019
por: Chen, Tao, et al.
Publicado: (2023)

Serum interleukin-6 in the diagnosis of bacterial infection in cirrhotic patients: A meta-analysis
por: Wu, Yinlian, et al.
Publicado: (2016)

Kidney disease and obesity paradox
por: Park, Jongha
Publicado: (2017)

Association Between Pulmonary Function and Nonalcoholic Fatty Liver Disease in the NHANES III Study
por: Peng, Tao-Chun, et al.
Publicado: (2015)

Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD
por: Huang, Jiaofeng, et al.
Publicado: (2022)

Syphilitic hepatitis: a case report and review of the literature
por: Huang, Jiaofeng, et al.
Publicado: (2019)

Authors response to correspondence regarding paper entitled Syphilitic hepatitis: a case report and review of the literature
por: Huang, Jiaofeng, et al.
Publicado: (2020)

The Association between Liver Enzymes and Mortality Stratified by Non-Alcoholic Fatty Liver Disease: An Analysis of NHANES III
por: Grob, Saskia Rita, et al.
Publicado: (2023)

Antiviral Therapy in Chronic Hepatitis B With Mild Acute Exacerbation
por: Lin, Su, et al.
Publicado: (2017)

The Obesity Paradox in Kidney Disease: How to Reconcile It With Obesity Management
por: Kalantar-Zadeh, Kamyar, et al.
Publicado: (2017)

Smoking and reverse causation create an obesity paradox in cardiovascular disease
por: Stokes, Andrew, et al.
Publicado: (2015)

Association between periodontitis and mortality in stages 3–5 chronic kidney disease: NHANES III and linked mortality study
por: Sharma, Praveen, et al.
Publicado: (2016)

The association between Toxoplasma infection and mortality: the NHANES epidemiologic follow-up study
por: Huang, Jiaofeng, et al.
Publicado: (2022)

Phenotypes of non-alcoholic fatty liver disease (NAFLD) and all-cause mortality: unsupervised machine learning analysis of NHANES III
por: Carrillo-Larco, Rodrigo M, et al.
Publicado: (2022)

Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006
por: Navaneethan, Sankar D., et al.
Publicado: (2012)

Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003–2018
por: Xie, Zhilan, et al.
Publicado: (2023)

Circadian Misalignment Rather Than Sleep Duration is Associated with MAFLD: A Population-Based Propensity Score-Matched Study
por: Weng, Zhiyuan, et al.
Publicado: (2021)

Clinical Factors Associated with Non-Obese Nonalcoholic Fatty Liver Disease Detected among US Adults in the NHANES 2017–2018
por: Razouki, Zayd Adnan, et al.
Publicado: (2022)

Association Between Metabolic Associated Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study from NHANES 2017–2018
por: Deng, Yunlei, et al.
Publicado: (2021)

Clearing Up the Obesity Paradox in Cardiac Surgery
por: Samuels, Jon D., et al.
Publicado: (2021)

All-Cause Mortality Risk of Metabolically Healthy Obese Individuals in NHANES III
por: Durward, C. M., et al.
Publicado: (2012)

Abdominal Obesity, Race and Chronic Kidney Disease in Young Adults: Results from NHANES 1999-2010
por: Sarathy, Harini, et al.
Publicado: (2016)

Association between Dietary Niacin Intake and Nonalcoholic Fatty Liver Disease: NHANES 2003–2018
por: Pan, Jie, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals
por: Cordeiro, A., et al.
Publicado: (2015)

The obesity paradox in chronic disease: facts and numbers
por: Lainscak, Mitja, et al.
Publicado: (2012)

“Obesity and Lean Paradox” in Peripheral Artery Disease
por: Lee, Seung Hun, et al.
Publicado: (2021)

Obesity Paradox in Lung Diseases: What Explains It?
por: Yao, Surui, et al.
Publicado: (2023)

Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up Study
por: Shavelle, Robert M, et al.
Publicado: (2009)

Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis
por: Zhao, Qianwen, et al.
Publicado: (2020)

Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease
por: Shi, Dongmei, et al.
Publicado: (2019)

Dietary Carotenoids and Non-Alcoholic Fatty Liver Disease among US Adults, NHANES 2003–2014
por: Christensen, Krista, et al.
Publicado: (2019)

Simpson's Paradox, Lord's Paradox, and Suppression Effects are the same phenomenon – the reversal paradox
por: Tu, Yu-Kang, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_3sfeth8vebupg7r2ddc97m8gie